LETYBO

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Malta, Romania, United Kingdom, United States

Active ingredients

The drug LETYBO contains one active pharmaceutical ingredient (API):

1 Botulinum toxin type A UNII E211KPY694 - BOTULINUM TOXIN TYPE A

Botulinum toxin type A is a protein complex derived from Clostridium botulinum. The protein consists of type A neurotoxin and several other proteins. Under physiological conditions it is presumed that the complex dissociates and releases the pure neurotoxin. Intramuscular injection of the neurotoxin complex blocks cholinergic transport at the neuromuscular junction by preventing the release of acetylcholine. The nerve endings of the neuromuscular junction no longer respond to nerve impulses and secretion of the chemotransmitter is prevented (chemical denervation). Read about Botulinum toxin type A

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LETYBO Powder for solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M03AX01	Botulinum toxin	M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AX Other muscle relaxants, peripherally acting agents
Discover more medicines within M03AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02528134, 02528142
Country: EE	Ravimiamet	Identifier(s): 3034875, 3034886, 3034909
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 87951
Country: FR	Base de données publique des médicaments	Identifier(s): 69878363
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-413273619
Country: IT	Agenzia del Farmaco	Identifier(s): 048945012, 048945024, 048945036, 048945048
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1098473, 1098474, 1098475, 1098476
Country: MT	Medicines Authority	Identifier(s): MA1493/00101
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68682001, W68682002, W68682003
Country: US	FDA, National Drug Code	Identifier(s): 81165-050, 81165-100